Literature DB >> 18007564

Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.

Robert Ma Hirschfeld1, Joseph R Calabrese, Mark A Frye, Philip W Lavori, Gary Sachs, Michael E Thase, Karen Dineen Wagner.   

Abstract

OBJECTIVE: This manuscript presents working definitions for key clinical course indicators for bipolar disorder, including response, remission, relapse, recurrence, and roughening.
METHOD: A work group of experts in bipolar disorder reviewed prior efforts to define clinical course indicators for unipolar depression and for schizophrenia. Using these efforts as templates, the work group developed consensus operational definitions. The rationale for each of the definitions was a point of time when a treatment decision needed to be made.
RESULTS: The group defined response as a 50% reduction in a score from a standard rating scale of symptomatology from an appropriate baseline, regardless of index episode type (manic, depressed, or mixed). In addition, the other pole cannot be significantly worsened during response. Remission was defined as absence or minimal symptoms of both mania and depression for at least 1 week. Sustained remission requires at least eight consecutive weeks of remission, and perhaps as many as 12 weeks. A relapse/recurrence was defined as a return to the full syndrome criteria of an episode of mania, mixed episode, or depression following a remission of any duration. Roughening was defined as a return of symptoms at a subsyndromal level, perhaps representing a prodrome of an impending episode.
CONCLUSIONS: The work group recommends that all reports of clinical trials in bipolar disorder include results using these definitions. This will introduce standards for such reports. Hopefully, the definitions will be revised and improved over time.

Entities:  

Mesh:

Year:  2007        PMID: 18007564

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  12 in total

1.  Achieving and sustaining remission in bipolar I disorder with ziprasidone : a post hoc analysis of a 24-week, double-blind, placebo-controlled study.

Authors:  Chi-Un Pae; Prakash S Masand; Francine S Mandel; Cedric O'Gorman
Journal:  Clin Drug Investig       Date:  2012-11       Impact factor: 2.859

2.  Profile and Determinants of Disability in Psychotic Disorders in Nigeria.

Authors:  Victor Olufolahan Lasebikan; Olatunde Ayinde
Journal:  Community Ment Health J       Date:  2016-12-01

3.  Customization in prescribing for bipolar disorder.

Authors:  Dominic Hodgkin; Joanna Volpe-Vartanian; Elizabeth L Merrick; Constance M Horgan; Andrew A Nierenberg; Richard G Frank; Sue Lee
Journal:  Health Econ       Date:  2011-04-19       Impact factor: 3.046

4.  Frequency of psychiatric comorbid symptoms in bipolar disorder patients in remission.

Authors:  Aarshie Koul; A Siddharth Shetty
Journal:  Ind Psychiatry J       Date:  2021-12-21

5.  LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder.

Authors:  Rodolfo N Campos; Luis F Costa; Danielle S Bio; Márcio G Soeiro de Souza; Carla R L Garcia; Frederico N Demétrio; Doris H Moreno; Ricardo A Moreno
Journal:  Trials       Date:  2010-06-23       Impact factor: 2.279

6.  Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.

Authors:  Diego Hidalgo-Mazzei; Michael Berk; Andrea Cipriani; Anthony J Cleare; Arianna Di Florio; Daniel Dietch; John R Geddes; Guy M Goodwin; Heinz Grunze; Joseph F Hayes; Ian Jones; Siegfried Kasper; Karine Macritchie; R Hamish McAllister-Williams; Richard Morriss; Sam Nayrouz; Sofia Pappa; Jair C Soares; Daniel J Smith; Trisha Suppes; Peter Talbot; Eduard Vieta; Stuart Watson; Lakshmi N Yatham; Allan H Young; Paul R A Stokes
Journal:  Br J Psychiatry       Date:  2018-12-06       Impact factor: 10.671

7.  The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole.

Authors:  Giovani Missio; Doris Hupfeld Moreno; Fernando Fernandes; Danielle Soares Bio; Márcio Gehardt Soeiro-de-Souza; Domingos Rodrigues dos Santos; Denise Petresco David; Luis Felipe Costa; Frederico Navas Demétrio; Ricardo Alberto Moreno
Journal:  Trials       Date:  2013-06-27       Impact factor: 2.279

8.  Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients.

Authors:  M Fornaro; B Stubbs; D De Berardis; F Iasevoli; M Solmi; N Veronese; A Carano; G Perna; A De Bartolomeis
Journal:  Clin Pract Epidemiol Ment Health       Date:  2016-12-23

9.  Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series.

Authors:  E A Holmes; M B Bonsall; S A Hales; H Mitchell; F Renner; S E Blackwell; P Watson; G M Goodwin; M Di Simplicio
Journal:  Transl Psychiatry       Date:  2016-01-26       Impact factor: 6.222

10.  Perceived stress, marital satisfaction, and sexual satisfaction in spouses of males having bipolar disorder with and without alcohol use disorder: A cross-sectional study.

Authors:  Sanchari Mukhopadhyay; Sneha Sharma; Apala Aggarwal; Dinesh Kataria
Journal:  Indian J Psychiatry       Date:  2021-06-17       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.